Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
Dr. Shebli Atrash received his medical education at Damascus University in Damascus, Syria. He completed a residency in internal medicine at St. Barnabas hospital/ Albert Einstein College of Medicine of Yeshiva University in the Bronx, NYC, New York, and a fellowship in hematology and oncology at the University of Arkansas for Medical Sciences in Little Rock, Arkansas. Dr. Atrash joined the Levine Cancer Institute faculty in July 2017; he also currently holds an academic appointment as Clinical Assistant Professor of Medicine at the University of North Carolina-Chapel Hill School of Medicine. Previously, Dr. Atrash served as an Assistant Professor of Medicine at the University of Arkansas for Medical Sciences in Little Rock, Arkansas.
Dr. Atrash is board-certified in internal medicine, medical oncology, and hematology. He holds membership in several professional societies, including the American college of physicians (ACP), the International Myeloma Working Group, the SWOG Myeloma Committee, the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO), and the American Society of Bone Marrow Transplantation. Dr. Atrash has authored/co-authored many peer-reviewed research manuscripts and abstracts at national and international meetings. Dr. Atrash has research interests focusing on plasma cell disorders, particularly CAR-T therapy and high-risk multiple myeloma.